Concurrent alcohol and tobacco dependence - Mechanisms and treatment

被引:0
|
作者
Drobes, DJ [1 ]
机构
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
关键词
comorbidity; AODD (alcohol and other drug dependence); alcoholic beverage; tobacco in any form; nicotine; smoking; genetic linkage; cross-tolerance; AOD (alcohol and other drug) sensitivity; neurotransmitters; brain reward pathway; cue reactivity; social AODU (AOD use); cessation of AODU; treatment outcome; combined modality therapy; literature review;
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
People who drink alcohol often also smoke and vice versa. Several mechanisms may contribute to concurrent alcohol and tobacco use. These mechanisms include genes that are involved in regulating certain brain chemical systems; neurobiological mechanisms, such as cross-tolerance and cross-sensitization to both drugs; conditioning mechanisms, in which cravings for alcohol or nicotine are elicited by certain environmental cues; and psychosocial factors (e.g., personality characteristics and coexisting psychiatric disorders). Treatment outcomes for patients addicted to both alcohol and nicotine are generally worse than for people addicted to only one drug, and many treatment providers do not promote smoking cessation during alcoholism treatment. Recent findings suggest, however, that concurrent treatment for both addictions may improve treatment outcomes.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 50 条
  • [1] Naltrexone treatment for concurrent tobacco and alcohol dependence.
    Mason, BJ
    Williams, LD
    Salvato, FR
    Mestre, S
    Cutler, RB
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (05) : 114A - 114A
  • [2] Concurrent treatment for alcohol and tobacco dependence: are patients ready to quit both?
    Stotts, AL
    Schmitz, JM
    Grabowski, J
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2003, 69 (01) : 1 - 7
  • [3] Overview - Alcohol and tobacco: Mechanisms and treatment
    Fertig, JB
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2002, 26 (12) : 1909 - 1910
  • [4] A Call to Action for Treatment of Comorbid Tobacco and Alcohol Dependence
    Evins, A. Eden
    Kelly, John F.
    [J]. JAMA PSYCHIATRY, 2018, 75 (02) : 121 - 122
  • [5] Concurrent Alcohol and Tobacco Treatment: Effect on Daily Process Measures of Alcohol Relapse Risk
    Cooney, Ned L.
    Litt, Mark D.
    Sevarino, Kevin A.
    Levy, Lucienne
    Kranitz, Linda S.
    Sackler, Helen
    Cooney, Judith L.
    [J]. JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2015, 83 (02) : 346 - 358
  • [6] Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence
    Hendricks, Peter S.
    Delucchi, Kevin L.
    Hall, Sharon M.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2010, 109 (1-3) : 114 - 119
  • [7] Pilot Cohorts for Development of Concurrent Mobile Treatment for Alcohol and Tobacco Use Disorders
    Medenblik, Alyssa M.
    Calhoun, Patrick S.
    Maisto, Stephen A.
    Kivlahan, Daniel R.
    Moore, Scott D.
    Beckham, Jean C.
    Wilson, Sarah M.
    Blalock, Dan, V
    Dedert, Eric A.
    [J]. SUBSTANCE ABUSE-RESEARCH AND TREATMENT, 2021, 15
  • [8] Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility
    Witkiewitz, Katie
    Saville, Kimber
    Hamreus, Kacie
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 45 - 53
  • [9] Epigenetic Mechanisms: Targets for Treatment of Alcohol Dependence and Drug Addiction
    Rahman, Shafiqur
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (02) : 101 - 101
  • [10] Pharmacological treatment of alcohol dependence: Target symptoms and target mechanisms
    Heilig, Markus
    Egli, Mark
    [J]. PHARMACOLOGY & THERAPEUTICS, 2006, 111 (03) : 855 - 876